Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters

Study ID: NCT07130773
Start Date: 2025-10
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

58

Intervention / Treatment

Second-generation FARAWAVE Nav catheter without the use of pre-ablation CT

FARAPULSE with pre-ablation CT

Sponsor

Cardiocentro Ticino

Source: clinicaltrials.gov

Share:
Add to list

Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans

Study ID: NCT06627569
Start Date: 2025-12-01
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

132

Intervention / Treatment

Exercise

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)

Study ID: NCT06456268
Start Date: 2025-09-30
End Date: 2026-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment

VibraCool mechanical stimulation and neuromodulatory therapeutic device

Cryocompression (Game Ready, Bregs) device

Standard ice packs

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Experiment Among Smokers in Which Two Variables Are Manipulated: Ostracism and Concealability

Study ID: NCT06462950
Start Date: 2028-05
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

340

Intervention / Treatment

Do men and women differ in their reactions to the experimental conditions.

Sponsor

Dickinson College

Source: clinicaltrials.gov

Share:
Add to list

Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)

Study ID: NCT07153497
Start Date: 2026-02-26
End Date: 2030-04-26
Study Type

Interventional

Study Phase

Phase2

No. of Participants

132

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Decitabine and Cedazuridine

Olutasse

Venetoclax

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Study ID: NCT07103746
Start Date: 2025-11
End Date: 2030-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Ublituximaab

Placebo for Ublituximab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

Improving Dietary Quality and Social Engagement Through a Virtual Nutrition and Teaching Kitchen Intervention Among Older Veterans With Impaired Mobility

Study ID: NCT06726083
Start Date: 2025-10-01
End Date: 2029-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Nutrition Intervention

Contact Control

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Study ID: NCT07169851
Start Date: 2025-10
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

204

Intervention / Treatment

To disturb 021

Placebo

Standard of Care Antiemetic Therapies

Background Chemotherapy

Sponsor

Eli Lilly and Company

Source: clinicaltrials.gov

Share:
Add to list

Structural and Intermediary Social Determinants of Oral Health Among Egyptian Women

Study ID: NCT04138550
Start Date: 2025-12-01
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

Misr International University

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons

Study ID: NCT05382091
Start Date: 2026-01-15
End Date: 2029-01-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

250

Intervention / Treatment

naltrexone implant

Sponsor

Go Medical Industries Pty Ltd

Source: clinicaltrials.gov

Share:
Add to list